Cargando…
Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis
Tuberous sclerosis complex (TSC) represents the prototypic monogenic disorder of the mammalian target of rapamycin (mTOR) pathway dysregulation. It provides the rational mechanistic basis of a direct link between gene mutation and brain pathology (structural and functional abnormalities) associated...
Autores principales: | Zimmer, Till S., Broekaart, Diede W. M., Gruber, Victoria-Elisabeth, van Vliet, Erwin A., Mühlebner, Angelika, Aronica, Eleonora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527496/ https://www.ncbi.nlm.nih.gov/pubmed/33041976 http://dx.doi.org/10.3389/fneur.2020.01028 |
Ejemplares similares
-
Astrocytes as Guardians of Neuronal Excitability: Mechanisms Underlying Epileptogenesis
por: Verhoog, Quirijn P., et al.
Publicado: (2020) -
Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy
por: Aronica, Eleonora, et al.
Publicado: (2023) -
Altered Extracellular Matrix as an Alternative Risk Factor for Epileptogenicity in Brain Tumors
por: de Jong, Jody M., et al.
Publicado: (2022) -
Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
por: Zimmer, Till S., et al.
Publicado: (2021) -
The Putative Role of mTOR Inhibitors in Non-tuberous Sclerosis Complex-Related Epilepsy
por: Goldstein, Hannah E., et al.
Publicado: (2021)